By: Emily Hung
Chinese University of Hong Kong scientists call GLP-1 ‘superstar pathway in biological, medical and pharmaceutical fields’.
Emily Hung is a Reporter at the South China Morning Post. She covers health news and policies in Hong Kong, with a strong focus on themes such as wellness, medicine, and healthcare, alongside regional interests and animal rights. Emily's work has been featured in prominent outlets including NBC News, CBS News, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Hong Kong, Hong Kong (Local)


Not enough data
Emily Hung's reporting focuses on a variety of local issues in China and Hong Kong, with an emphasis on government policies, crime, travel & tourism, healthcare & pharmaceuticals, and family & relationships. She often includes expert commentary and covers government announcements.
To effectively reach out to Emily Hung, consider providing insights related to local government initiatives or policies in China or Hong Kong. If you have expertise in areas such as healthcare systems, transportation infrastructure, tourism trends within the region or analysis of social issues impacting families and communities in this area would be valuable for her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .